{"id":6425,"date":"2024-03-26T17:36:54","date_gmt":"2024-03-26T16:36:54","guid":{"rendered":"https:\/\/www.institutmacula.com\/?p=6425"},"modified":"2024-03-26T18:47:56","modified_gmt":"2024-03-26T17:47:56","slug":"prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto","status":"publish","type":"post","link":"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/","title":{"rendered":"Prof. Jordi Mon\u00e9s, sobre el pegcetacoplan contra la DMAE atr\u00f3fica: \u00abSigo esperando que la EMA rectifique muy pronto\u00bb"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"6425\" class=\"elementor elementor-6425 elementor-6399\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-682fa87d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"682fa87d\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-57196545\" data-id=\"57196545\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4b2479d0 elementor-widget elementor-widget-text-editor\" data-id=\"4b2479d0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>El Dr. Jordi Mon\u00e9s ha exposat, en dos importants f\u00f2rums oftalmol\u00f2gics celebrats a Atenes i a Madrid, la preocupaci\u00f3 sobre la posici\u00f3 de l\u2019Ag\u00e8ncia Europea de Medicaments respecte de l&#8217;autoritzaci\u00f3 de Syfovre (pegcetacoplan, Apellis Pharmaceutical), el primer dels dos f\u00e0rmacs aprovats als Estats Units per al tractament de la DMAE atr\u00f2fica. En un post publicat a la xarxa professional LinkedIn, el director de l\u2019Institut de la M\u00e0cula qualifica de decebedor el fet \u00abque l\u2019EMA no hagi compr\u00e8s les complexitats i l\u2019heterogene\u00eftat inherents a aquesta patologia i no hagi donat suport almenys al tractament per als pacients d\u2019alt risc, que perden la visi\u00f3 tan r\u00e0pidament\u00bb. El professor Mon\u00e9s posa el focus en la \u00abiniquitat\u00bb que representa \u00abla falta de disponibilitat de ter\u00e0pia per als pacients europeus, en contrast amb l\u2019accessibilitat als Estats Units\u00bb, un fet que justificaria \u00abuna prompta resoluci\u00f3\u00bb.<\/p><p>Segons el Dr. Mon\u00e9s, \u00aben tractar la DMAE exsudativa [una patologia per a la qual s\u00ed hi ha f\u00e0rmacs aprovats], ens enfrontem als desafiaments diaris que plantegen afeccions potencialment perilloses per a la visi\u00f3, com l\u2019endoftalmitis. Tot i aquests riscs, no q\u00fcestionem la ter\u00e0pia perqu\u00e8 els beneficis de prevenir la p\u00e8rdua visual greu superen amb escreix els riscos. I aquesta \u00e9s la q\u00fcesti\u00f3\u00bb.<\/p><p>I continua: \u00abSyfovre i Izervay [el segon dels f\u00e0rmacs que l\u2019FDA nordamericana ha aprovat contra la DMAE atr\u00f2fica, pendent encara de la resoluci\u00f3 de l\u2019EMA] han demostrat una efic\u00e0cia significativa en la desacceleraci\u00f3 de la progressi\u00f3 de les lesions de l\u2019atr\u00f2fia geogr\u00e0fica i en la preservaci\u00f3 de la funci\u00f3 visual en pacients amb lesions que avancen r\u00e0pidament. \u00c9s essencial recon\u00e8ixer que, si b\u00e9 les conclusions prim\u00e0ries s\u00f3n crucials per a l&#8217;aprovaci\u00f3 regulat\u00f2ria, \u00e9s possible que no aclareixin completament quins pacients obtindrien beneficis substancials del tractament. Els criteris de valoraci\u00f3 secundaris i les an\u00e0lisis <em>post-hoc<\/em> ofereixen informaci\u00f3 valuosa sobre els subgrups de pacients que m\u00e9s es beneficiarien de la ter\u00e0pia\u00bb.<\/p><p>Podeu llegir el post del Dr. Jordi Mon\u00e9s <a href=\"https:\/\/www.linkedin.com\/feed\/update\/urn:li:activity:7178366806946889728?updateEntityUrn=urn%3Ali%3Afs_feedUpdate%3A%28V2%2Curn%3Ali%3Aactivity%3A7178366806946889728%29\">aqu\u00ed<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>El Dr. Jordi Mon\u00e9s ha expuesto, en dos importantes foros oftalmol\u00f3gicos celebrados en Atenas y en Madrid, la preocupaci\u00f3n sobre la posici\u00f3n de la Agencia Europea de Medicamentos respecto a la autorizaci\u00f3n de Syfovre (pegcetacoplan, Apellis Pharmaceutical), el primero de los dos f\u00e1rmacos aprobados en Estados Unidos para el tratamiento de la DMAE atr\u00f3fica. En [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":6402,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,33],"tags":[54,53,59,58,56,57,55],"class_list":["post-6425","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home","category-noticias","tag-atrofica-geografica","tag-dmae-atrofica-2","tag-ema","tag-fda","tag-izervay-2","tag-pegcetacoplan-2","tag-syfovre-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Prof. Jordi Mon\u00e9s, sobre el pegcetacoplan contra la DMAE atr\u00f3fica: \u00abSigo esperando que la EMA rectifique muy pronto\u00bb - Institut de la M\u00e0cula<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prof. Jordi Mon\u00e9s, sobre el pegcetacoplan contra la DMAE atr\u00f3fica: \u00abSigo esperando que la EMA rectifique muy pronto\u00bb - Institut de la M\u00e0cula\" \/>\n<meta property=\"og:description\" content=\"El Dr. Jordi Mon\u00e9s ha expuesto, en dos importantes foros oftalmol\u00f3gicos celebrados en Atenas y en Madrid, la preocupaci\u00f3n sobre la posici\u00f3n de la Agencia Europea de Medicamentos respecto a la autorizaci\u00f3n de Syfovre (pegcetacoplan, Apellis Pharmaceutical), el primero de los dos f\u00e1rmacos aprobados en Estados Unidos para el tratamiento de la DMAE atr\u00f3fica. En [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/\" \/>\n<meta property=\"og:site_name\" content=\"Institut de la M\u00e0cula\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-26T16:36:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-26T17:47:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/03\/MONES-SERV-2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"maties\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"maties\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/\"},\"author\":{\"name\":\"maties\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#\/schema\/person\/7132d3f447c8d1fc4507e3c9f72dcfaa\"},\"headline\":\"Prof. Jordi Mon\u00e9s, sobre el pegcetacoplan contra la DMAE atr\u00f3fica: \u00abSigo esperando que la EMA rectifique muy pronto\u00bb\",\"datePublished\":\"2024-03-26T16:36:54+00:00\",\"dateModified\":\"2024-03-26T17:47:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/\"},\"wordCount\":393,\"publisher\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/03\/MONES-SERV-2.jpeg\",\"keywords\":[\"Atr\u00f3fica geogr\u00e1fica\",\"DMAE atr\u00f3fica\",\"EMA\",\"FDA\",\"Izervay\",\"pegcetacoplan\",\"Syfovre\"],\"articleSection\":[\"Home\",\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/\",\"url\":\"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/\",\"name\":\"Prof. Jordi Mon\u00e9s, sobre el pegcetacoplan contra la DMAE atr\u00f3fica: \u00abSigo esperando que la EMA rectifique muy pronto\u00bb - Institut de la M\u00e0cula\",\"isPartOf\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/03\/MONES-SERV-2.jpeg\",\"datePublished\":\"2024-03-26T16:36:54+00:00\",\"dateModified\":\"2024-03-26T17:47:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/#primaryimage\",\"url\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/03\/MONES-SERV-2.jpeg\",\"contentUrl\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/03\/MONES-SERV-2.jpeg\",\"width\":1024,\"height\":683},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/www.institutmacula.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prof. Jordi Mon\u00e9s, sobre el pegcetacoplan contra la DMAE atr\u00f3fica: \u00abSigo esperando que la EMA rectifique muy pronto\u00bb\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#website\",\"url\":\"https:\/\/www.institutmacula.com\/es\/\",\"name\":\"Institut de la M\u00e0cula\",\"description\":\"Innovating Eye Care\",\"publisher\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.institutmacula.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#organization\",\"name\":\"Institut de la M\u00e0cula\",\"url\":\"https:\/\/www.institutmacula.com\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/02\/logo-Institut-de-la-Macula-24.png\",\"contentUrl\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/02\/logo-Institut-de-la-Macula-24.png\",\"width\":300,\"height\":120,\"caption\":\"Institut de la M\u00e0cula\"},\"image\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#\/schema\/person\/7132d3f447c8d1fc4507e3c9f72dcfaa\",\"name\":\"maties\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prof. Jordi Mon\u00e9s, sobre el pegcetacoplan contra la DMAE atr\u00f3fica: \u00abSigo esperando que la EMA rectifique muy pronto\u00bb - Institut de la M\u00e0cula","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/","og_locale":"es_ES","og_type":"article","og_title":"Prof. Jordi Mon\u00e9s, sobre el pegcetacoplan contra la DMAE atr\u00f3fica: \u00abSigo esperando que la EMA rectifique muy pronto\u00bb - Institut de la M\u00e0cula","og_description":"El Dr. Jordi Mon\u00e9s ha expuesto, en dos importantes foros oftalmol\u00f3gicos celebrados en Atenas y en Madrid, la preocupaci\u00f3n sobre la posici\u00f3n de la Agencia Europea de Medicamentos respecto a la autorizaci\u00f3n de Syfovre (pegcetacoplan, Apellis Pharmaceutical), el primero de los dos f\u00e1rmacos aprobados en Estados Unidos para el tratamiento de la DMAE atr\u00f3fica. En [&hellip;]","og_url":"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/","og_site_name":"Institut de la M\u00e0cula","article_published_time":"2024-03-26T16:36:54+00:00","article_modified_time":"2024-03-26T17:47:56+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/03\/MONES-SERV-2.jpeg","type":"image\/jpeg"}],"author":"maties","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"maties","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/#article","isPartOf":{"@id":"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/"},"author":{"name":"maties","@id":"https:\/\/www.institutmacula.com\/es\/#\/schema\/person\/7132d3f447c8d1fc4507e3c9f72dcfaa"},"headline":"Prof. Jordi Mon\u00e9s, sobre el pegcetacoplan contra la DMAE atr\u00f3fica: \u00abSigo esperando que la EMA rectifique muy pronto\u00bb","datePublished":"2024-03-26T16:36:54+00:00","dateModified":"2024-03-26T17:47:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/"},"wordCount":393,"publisher":{"@id":"https:\/\/www.institutmacula.com\/es\/#organization"},"image":{"@id":"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/#primaryimage"},"thumbnailUrl":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/03\/MONES-SERV-2.jpeg","keywords":["Atr\u00f3fica geogr\u00e1fica","DMAE atr\u00f3fica","EMA","FDA","Izervay","pegcetacoplan","Syfovre"],"articleSection":["Home","Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/","url":"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/","name":"Prof. Jordi Mon\u00e9s, sobre el pegcetacoplan contra la DMAE atr\u00f3fica: \u00abSigo esperando que la EMA rectifique muy pronto\u00bb - Institut de la M\u00e0cula","isPartOf":{"@id":"https:\/\/www.institutmacula.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/#primaryimage"},"image":{"@id":"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/#primaryimage"},"thumbnailUrl":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/03\/MONES-SERV-2.jpeg","datePublished":"2024-03-26T16:36:54+00:00","dateModified":"2024-03-26T17:47:56+00:00","breadcrumb":{"@id":"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/#primaryimage","url":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/03\/MONES-SERV-2.jpeg","contentUrl":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/03\/MONES-SERV-2.jpeg","width":1024,"height":683},{"@type":"BreadcrumbList","@id":"https:\/\/www.institutmacula.com\/es\/prof-jordi-mones-sobre-el-pegcetacoplan-contra-la-dmae-atrofica-sigo-esperando-que-la-ema-rectifique-muy-pronto\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/www.institutmacula.com\/es\/"},{"@type":"ListItem","position":2,"name":"Prof. Jordi Mon\u00e9s, sobre el pegcetacoplan contra la DMAE atr\u00f3fica: \u00abSigo esperando que la EMA rectifique muy pronto\u00bb"}]},{"@type":"WebSite","@id":"https:\/\/www.institutmacula.com\/es\/#website","url":"https:\/\/www.institutmacula.com\/es\/","name":"Institut de la M\u00e0cula","description":"Innovating Eye Care","publisher":{"@id":"https:\/\/www.institutmacula.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.institutmacula.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.institutmacula.com\/es\/#organization","name":"Institut de la M\u00e0cula","url":"https:\/\/www.institutmacula.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.institutmacula.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/02\/logo-Institut-de-la-Macula-24.png","contentUrl":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/02\/logo-Institut-de-la-Macula-24.png","width":300,"height":120,"caption":"Institut de la M\u00e0cula"},"image":{"@id":"https:\/\/www.institutmacula.com\/es\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.institutmacula.com\/es\/#\/schema\/person\/7132d3f447c8d1fc4507e3c9f72dcfaa","name":"maties"}]}},"_links":{"self":[{"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/posts\/6425","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/comments?post=6425"}],"version-history":[{"count":2,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/posts\/6425\/revisions"}],"predecessor-version":[{"id":6427,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/posts\/6425\/revisions\/6427"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/media\/6402"}],"wp:attachment":[{"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/media?parent=6425"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/categories?post=6425"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/tags?post=6425"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}